q&a: difference between autologous vs. allogeneic transplant in myeloma? - blood cancer onctalk 2023
Published 6 months ago • 18 plays • Length 3:32Download video MP4
Download video MP3
Similar videos
-
8:20
q&a: autologous transplant for young standard-risk myeloma patients? - blood cancer onctalk 2023
-
7:23
autologous bone marrow transplants: use in myeloma and lymphoma - blood cancer onctalk 2023
-
7:55
what is a bone marrow transplant? - blood cancer onctalk 2023
-
3:53
identifying smoldering multiple myeloma patients: risk factors - blood cancer onctalk 2023
-
3:13
q&a: is multiple myeloma a myelogenous cancer? - blood cancer onctalk 2023
-
4:32
what is multiple myeloma? - blood cancer onctalk
-
2:44
the future of multiple myeloma treatment - blood cancer onctalk
-
3:38
what is the difference between autologous and allogeneic transplant?
-
1:21
q&a: exploring correlation: von willebrand factor and smoldering myeloma - blood cancer onctalk 2023
-
1:44
multiple myeloma - should everyone receive an autologous transplant?
-
3:12
what are the pros and cons of car t-cell therapy vs. bispecific antibodies? - blood cancer onctalk
-
7:39
car t-cell versus bispecific therapies: how oncologists determine treatment - blood cancer onctalk
-
3:01
is there a preference for type of car t-cell treatment? - blood cancer onctalk
-
2:01
should everyone receive an autologous transplant?
-
3:41
q&a: what can patients do to close the biomarker testing gap?-targeted therapies in lung cancer 2023
-
14:15
debate: one size fits all? should everyone eligible get upfront autologous sct - pro
-
2:48
can car-t therapy be used in conjunction with or instead of autologous transplantation in myeloma?
-
3:23
q&a: what tt options exist for patients with driver mutations? - targeted therapies in lung cancer
-
4:22
what is grace?